{"brief_title": "Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)", "brief_summary": "The purpose of this study is to determine if therapy with pioglitazone or vitamin E will lead to an improvement in liver histology in non-diabetic adult patients with non-alcoholic steatohepatitis (NASH).", "detailed_description": "The purpose of this study is to determine if therapy with pioglitazone or vitamin E will lead to an improvement in liver histology in non-diabetic adult patients with non-alcoholic steatohepatitis (NASH).", "condition": "Liver Diseases", "intervention_type": "Drug", "intervention_name": "Matching placebo", "description": "Daily", "arm_group_label": "3", "other_name": "Nature Made", "criteria": "- Histologic evidence of NASH based on a liver biopsy obtained within 6 months of randomization. - Age 18 years or older", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00063622.xml"}